A Backlash Materializes Against Soaring EpiPen Prices

A Backlash Materializes Against Soaring EpiPen Prices

Monsanto Shares Climb on Report of Constructive Bayer AG Takeover Talks

Monsanto Shares Climb on Report of Constructive Bayer AG Takeover Talks

Midday Report: Monsanto Rises on Deal Reports; U.S. Stocks Climb

Midday Report: Monsanto Rises on Deal Reports; U.S. Stocks Climb

Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors

Merck Potential Blockbuster Drug, Key Acquisition Make It a Good Bet for Investors

Valeant's C-Suite Sees Another Shake-Up

Valeant's C-Suite Sees Another Shake-Up

Valeant Shares Rise on New CFO Appointment

Valeant Shares Rise on New CFO Appointment

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

Pfizer Buys Medivation, the Crown Jewel in Cancer Therapy

Gilead May Be Better Off Splitting Itself in Two, Analysts Say

Gilead May Be Better Off Splitting Itself in Two, Analysts Say

Valeant Pharmaceuticals Rallies on Morgan Stanley Upgrade

Valeant Pharmaceuticals Rallies on Morgan Stanley Upgrade

Morgan Stanley Says It's Time to Buy Valeant Again

Morgan Stanley Says It's Time to Buy Valeant Again